Theralizumab
Product Specifications
CAS Number
906068-56-2
Target
Others|||Immunology/Inflammation related
Related Pathways
Others|||Immunology/Inflammation
Purity
0.9946
Bioactivity
Theralizumab (TGN1412) is an anti-CD28-targeting monoclonal antibody that directly stimulates T cells. Theralizumab has antitumor activity and is used for the treatment of B-cell chronic lymphocytic leukemia and rheumatoid arthritis.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/64416431076278315/T77093
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
IRBAMLSYN1AP93120UL 120 µL
Rabbit Anti Human SYN1 Polyclonal Affinity Purified (PBS with 0.05% sodium azide and 50% glycerol, pH7.4) (Western Blot,ELISA) 120UL
Ask
View Details 
MBS7185637 Inquire
Rabbit anti-Escherichia coli (strain SMS-3-5/SECEC) ZAPB Polyclonal Antibody
Ask
View Details